RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
WuXi Biologics (Cayman) - Stock

WuXi Biologics (Cayman) ROCE 2024

WuXi Biologics (Cayman) ROCE

0.1

Ticker

2269.HK

ISIN

KYG970081173

WKN

A2QJCN

In 2024, WuXi Biologics (Cayman)'s return on capital employed (ROCE) was 0.1, a -20.93% increase from the 0.13 ROCE in the previous year.

WuXi Biologics (Cayman) Aktienanalyse

What does WuXi Biologics (Cayman) do?

WuXi Biologics (Cayman) Inc. is a company specializing in the development and manufacturing of biopharmaceuticals. It was founded in 2015 and is headquartered in Shanghai, China. WuXi Biologics is the world's largest biologics development and manufacturing services company and is also listed on the Hong Kong Stock Exchange. WuXi Biologics (Cayman) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling WuXi Biologics (Cayman)'s Return on Capital Employed (ROCE)

WuXi Biologics (Cayman)'s Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing WuXi Biologics (Cayman)'s ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

WuXi Biologics (Cayman)'s ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in WuXi Biologics (Cayman)’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about WuXi Biologics (Cayman) Stock

What is the ROCE (Return on Capital Employed) of WuXi Biologics (Cayman) this year?

The ROCE of WuXi Biologics (Cayman) is 0.1 undefined this year.

How has the ROCE (Return on Capital Employed) of WuXi Biologics (Cayman) developed compared to the previous year?

The ROCE of WuXi Biologics (Cayman) has increased by -20.93% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of WuXi Biologics (Cayman)?

A high Return on Capital Employed (ROCE) indicates that WuXi Biologics (Cayman) has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of WuXi Biologics (Cayman)?

A low ROCE (Return on Capital Employed) can indicate that WuXi Biologics (Cayman) has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from WuXi Biologics (Cayman) impact the company?

An increase in the ROCE of WuXi Biologics (Cayman) can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of WuXi Biologics (Cayman) affect the company?

A decrease in ROCE of WuXi Biologics (Cayman) can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of WuXi Biologics (Cayman)?

Some factors that can affect WuXi Biologics (Cayman)'s ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of WuXi Biologics (Cayman) so important for investors?

The ROCE of WuXi Biologics (Cayman) is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can WuXi Biologics (Cayman) take to improve the ROCE?

To improve the ROCE, WuXi Biologics (Cayman) can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does WuXi Biologics (Cayman) pay?

Over the past 12 months, WuXi Biologics (Cayman) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, WuXi Biologics (Cayman) is expected to pay a dividend of 0 CNY.

What is the dividend yield of WuXi Biologics (Cayman)?

The current dividend yield of WuXi Biologics (Cayman) is .

When does WuXi Biologics (Cayman) pay dividends?

WuXi Biologics (Cayman) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of WuXi Biologics (Cayman)?

WuXi Biologics (Cayman) paid dividends every year for the past 0 years.

What is the dividend of WuXi Biologics (Cayman)?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is WuXi Biologics (Cayman) located?

WuXi Biologics (Cayman) is assigned to the 'Health' sector.

Wann musste ich die Aktien von WuXi Biologics (Cayman) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of WuXi Biologics (Cayman) from 7/2/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 7/2/2024.

When did WuXi Biologics (Cayman) pay the last dividend?

The last dividend was paid out on 7/2/2024.

What was the dividend of WuXi Biologics (Cayman) in the year 2023?

In the year 2023, WuXi Biologics (Cayman) distributed 0 CNY as dividends.

In which currency does WuXi Biologics (Cayman) pay out the dividend?

The dividends of WuXi Biologics (Cayman) are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von WuXi Biologics (Cayman)

Our stock analysis for WuXi Biologics (Cayman) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of WuXi Biologics (Cayman) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.